Drug interactions with sunitinib

…, BS Jose, LR Lopez-Gimenez… - Journal of Oncology …, 2015 - journals.sagepub.com
Purpose Sunitinib is a tyrosine kinase inhibitor indicated for the treatment of gastrointestinal
stromal tumor, advanced renal cell carcinoma, and pancreatic neuroendocrine tumors. The …

Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units

A De Basagoiti, A Katsumiti, S Abascal… - European Journal of …, 2021 - Springer
This study aimed to determine the physical compatibility of alprostadil with 17 continuous
infusion drugs commonly administered in neonatal intensive care units. Test samples were …

Medication reconciliation at hospital admission: Results and identification of target patients

B San José Ruiz, L Serrano De Lucas… - Revista de Calidad …, 2016 - europepmc.org
[Medication reconciliation at hospital admission: Results and identification of target patients]. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

CP-001 Antibiotic strategy after the empirical phase in hospitalised pacients with positive blood cultures

CA Meriel, LRL Giménez, AG Esteban… - European Journal of …, 2014 - ejhp.bmj.com
Background Inappropriate antimicrobial treatment in bloodstream infections is associated
with increased mortality rates and health cost. Purpose To assess the adequacy and …

CP-094 Discontinuation of enzyme replacement treatment with imiglucerase

LRL Giménez, AG Esteban, CA Meriel… - European Journal of …, 2014 - ejhp.bmj.com
Background The imiglucerase drug shortages in 2009 forced a change in the treatment of
many patients with Gaucher's disease. Purpose To describe the clinical outcomes of an …

PS-032 Antiretroviral drug prescribing errors in hospitalised patients

AG Esteban, CA Meriel, LRL Giménez… - European Journal of …, 2014 - ejhp.bmj.com
Background Errors in prescribing antiretroviral treatment (ART) are common during the
hospitalisation of HIV patients. Interventions to prevent and correct errors improve the quality …

DI-068 Chromatopsia and night blindness in a patient on capecitabine and temozolomide

GR Bernaola, ADB Gorordo, AB Foronda, SM Garcia… - 2016 - ejhp.bmj.com
Background Patients with chemosensitive neuroendocrine tumours are often treated with a
capecitabine protocol (750 mg/m 2/12 h day 1 to day 14) and temozolomide (200 mg/m 2/24 …

GRP-049 Design and Development of a Prescription Module of Enteral Diets For a Neonatal Unit

JJM Garde, LRL Giménez, MV Domínguez… - European Journal of …, 2013 - ejhp.bmj.com
Background A safety problem occurred in requesting enteral diets (EDs) in the neonatal unit.
So we decided to develop a special prescription module for requesting EDs. Purpose To …

PP-029 Non-comedogenic formulation of topical sirolimus for tuberous sclerosis patients with facial angiofibromas developing acne cosmetica

GR Bernaola, ADB Gorordo, AB Foronda, IB Meseguer… - 2015 - ejhp.bmj.com
Background Patients with tuberous sclerosis often develop facial angiofibromas that can be
successfully treated with topical 1% sirolimus ointments. Nevertheless, this ointment's …

Conciliación de la medicación al ingreso: resultados e identificación de pacientes diana

BSJ Ruiz, LS De Lucas, LR López-Giménez… - Revista de Calidad …, 2016 - Elsevier
Objetivo Identificar y cuantificar las discrepancias entre el tratamiento prescrito al ingreso
hospitalario y el tratamiento crónico del paciente. Identificar variables que puedan utilizarse …